Dynamic markers of intraoperative instability
术中不稳定性的动态标记
基本信息
- 批准号:8297002
- 负责人:
- 金额:$ 34.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdverse eventAgeAmericanAnesthesia proceduresAnestheticsBlindedBlood PressureBypassCardiacCardiac Surgery proceduresCardiopulmonaryCardiopulmonary BypassCardiovascular Surgical ProceduresCardiovascular systemCerebrumCessation of lifeCharacteristicsClinicalComplexCoronary arteryCounselingDataData SetDatabasesDecision MakingDiscriminationEarly DiagnosisEntropyEventFrequenciesFutureGeneral PopulationGoalsHealth Care CostsHeart failureHomeostasisHospitalizationHospitalsHypertensionIndividualInformation SystemsInterventionKidney FailureLeadLegal patentLinear ModelsMeasurementMeasuresMethodsMetricModelingMonitorMotivationMyocardial InfarctionNon-linear ModelsOperating RoomsOperative Surgical ProceduresOutcomePatientsPerformancePerfusionPerioperativePhysiciansPhysiologicalPopulationPostoperative PeriodPredictive ValueProceduresPropertyProviderPulse PressureResearchResearch PersonnelResource AllocationResourcesRiskRisk AssessmentSchemeSignal TransductionSocietiesSolutionsSpinal CordStagingStratificationStrokeSystemSystems TheoryTestingThoracic SurgeonTimeUnited States National Institutes of Healthbaseblood pressure regulationcardiovascular risk factorcomputerized toolscosthemodynamicshigh riskimprovedindexinginsightmortalitynovelpreventprogramsprospectivetooltreatment strategy
项目摘要
DESCRIPTION (provided by applicant): The broad, long-term objective of this research is to develop real-time dynamic cardiovascular risk indices to help predict outcomes and guide management of high-risk patients undergoing complex procedures. As high-cardiovascular risk patients present for complex cardiovascular surgery, the frequency of major adverse perioperative events (MAE) such as stroke, heart failure, and myocardial infarction has increased and is associated with longer hospitalization, increased mortality, and increased health care costs. Traditional "static" metrics of risk stratification, such as age or co morbid conditions, are not able to predict which patients are at risk for MAE or offer insights into individualized treatment strategies. These approaches fail to take into account fluctuations in physiologic control in individual patents and use simplified linear models that are unable to capture the complex, time varying features that are hallmarks of 'real-world' physiological signals. This project will apply state-of-the-art nonlinear methods to real-time intraoperative blood pressure signals and create a novel dynamical set of indices that facilitate early detection of subtle intraoperative hemodynamic disturbances. By relating these complex intraoperative signals to MAE, determined from the validated Society of Thoracic Surgeons (STS) National outcomes database, hemodynamic "signatures" with predictive value for MAE will be determined. To achieve these goals, the three specific aims of the proposed program are: 1) To determine a) if BPV is fixed for a given individual at various stages of surgery, b) BPV's predictive ability for postoperative MAE following cardiac surgery 2) To test the change in BPV from baseline to post-CPB periods as more predictive of MAE than either baseline or post-CPB BPV and to validate BPV's predictive ability of outcome 3) To create a unique open access database (preoperative, intraoperative hemodynamic signal recordings plus postoperative outcome data) publicly available via the NIH-sponsored PhysioNet Research Resource for Complex Physiologic Signals (www.physionet.org). The intraoperative beat-by-beat hemodynamic data will be collected directly from the operating room monitors and will be integrated with the automated anesthesia information systems and STS outcome database. The data will be deidentified and analyzed with multi scale entropy. The entropy data will be tested for its MAE predictive ability and compared to the traditional STS risk indices by itself or as a part of it. The entropy range at which the postoperative outcome is optimal will be determined and used as guidance for future interventional studies. The proposed dynamic approach offers a promising solution for patient level discrimination; improve patient counseling, intraoperative hemodynamic management and postoperative outcome.
PUBLIC HEALTH RELEVANCE:
Americans are surviving to increasingly old age and requiring high-risk surgery. However, physicians are hampered by the limitations of conventional methods in predicting operative risk and tailoring surgical and anesthetic management to optimize outcomes. This study will provide new non- invasive approaches to assessing risk and reduce adverse events and their attendant costs.
描述(由申请人提供):这项研究的广泛、长期目标是开发实时动态心血管风险指数,以帮助预测结果并指导正在进行复杂程序的高危患者的管理。随着心血管高危患者接受复杂的心血管手术,中风、心力衰竭和心肌梗死等围术期主要不良事件(MAE)的发生率增加,并与更长的住院时间、更高的死亡率和更高的医疗费用相关。传统的风险分层的“静态”指标,如年龄或合并症,不能预测哪些患者有患MAE的风险,也不能为个体化治疗策略提供见解。这些方法未能考虑到个别专利中生理控制的波动,并使用简化的线性模型,无法捕捉复杂的、时变的特征,而这些特征是“真实世界”生理信号的标志。该项目将把最先进的非线性方法应用于术中实时血压信号,并创建一套新的动态指标,有助于及早检测微妙的术中血流动力学障碍。通过将这些复杂的术中信号与MAE相关联,从经过验证的胸外科医生协会(STS)国家结果数据库确定MAE,将确定具有MAE预测值的血流动力学“特征”。为了实现这些目标,拟议计划的三个具体目标是:1)确定BPV在手术的不同阶段是否对特定个人是固定的,b)BPV对心脏手术后MAE的预测能力2)测试BPV从基线到CPB后期间的变化是否比基线或CPB后BPV更能预测MAE,并验证BPV对结果的预测能力3)创建一个独特的开放访问数据库(术前、术中血流动力学信号记录加上术后结果数据),可通过NIH赞助的复杂生理信号的PhysioNet研究资源(www.Physionet.org)公开获得。术中逐次血流动力学数据将直接从手术室监护仪收集,并将与自动麻醉信息系统和STS结果数据库集成。利用多尺度熵对数据进行识别和分析。将测试熵数据的MAE预测能力,并将其与传统的STS风险指数单独或作为其一部分进行比较。术后结果最佳的熵范围将被确定并用作未来介入研究的指导。所提出的动态方法为区分患者级别提供了一个有希望的解决方案;改善了患者咨询、术中血流动力学管理和术后结果。
公共卫生相关性:
美国人的寿命越来越长,需要进行高风险的手术。然而,医生在预测手术风险和调整手术和麻醉管理以优化结果方面受到传统方法的限制。这项研究将提供新的非侵入性方法来评估风险并减少不良事件及其伴随的成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Balachundhar Subramaniam其他文献
Balachundhar Subramaniam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Balachundhar Subramaniam', 18)}}的其他基金
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 34.68万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 34.68万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 34.68万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 34.68万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 34.68万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 34.68万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 34.68万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 34.68万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 34.68万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 34.68万 - 项目类别: